Current challenges in understanding the role of enhancers in disease

0567380 - ÚMG 2023 RIV US eng J - Článek v odborném periodiku
Zaugg, J. B. - Sahlen, P. - Andersson, R. - Alberich-Jorda, Meritxell - de Laat, W. - Deplancke, B. - Ferrer, J. - Mandrup, S. - Natoli, G. - Plewczynski, D. - Rada-Iglesias, A. - Spicuglia, S.
Current challenges in understanding the role of enhancers in disease.
Nature Structural & Molecular Biology. Roč. 29, č. 12 (2022), s. 1148-1158. ISSN 1545-9993. E-ISSN 1545-9985
GRANT EU: European Commission(XE) 860002 - ENHPATHY
Institucionální podpora: RVO:68378050
Klíčová slova: beta-globin gene * shadow enhancers * burkitt-lymphoma * super-enhacers * single-cell * chromatin * expression * variants * identification * dissection
Obor OECD: Biochemistry and molecular biology
Impakt faktor: 16.8, rok: 2022
Způsob publikování: Omezený přístup
https://www.nature.com/articles/s41594-022-00896-3

Enhancers play a central role in the spatiotemporal control of gene expression and tend to work in a cell-type-specific manner. In addition, they are suggested to be major contributors to phenotypic variation, evolution and disease. There is growing evidence that enhancer dysfunction due to genetic, structural or epigenetic mechanisms contributes to a broad range of human diseases referred to as enhanceropathies. Such mechanisms often underlie the susceptibility to common diseases, but can also play a direct causal role in cancer or Mendelian diseases. Despite the recent gain of insights into enhancer biology and function, we still have a limited ability to predict how enhancer dysfunction impacts gene expression. Here we discuss the major challenges that need to be overcome when studying the role of enhancers in disease etiology and highlight opportunities and directions for future studies, aiming to disentangle the molecular basis of enhanceropathies.
Trvalý link: https://hdl.handle.net/11104/0338881